Cargando…
Gut microbiome metabolites as key actors in atherosclerosis co-depression disease
Cardiovascular diseases, mainly characterized by atherosclerosis (AS), and depression have a high comorbidity rate. However, previous studies have been conducted under a single disease, and there is a lack of studies in comorbid states to explore the commonalities in the pathogenesis of both disease...
Autores principales: | Liao, Xing-Xing, Wu, Xiao-Yun, Zhou, Yu-Long, Li, Jia-Jun, Wen, You-Liang, Zhou, Jun-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686300/ https://www.ncbi.nlm.nih.gov/pubmed/36439791 http://dx.doi.org/10.3389/fmicb.2022.988643 |
Ejemplares similares
-
Gut microbiome and metabolites: The potential key roles in pulmonary fibrosis
por: Wu, Yinlan, et al.
Publicado: (2022) -
Effects of the Lipid Metabolites and the Gut Microbiota in ApoE(−/−) Mice on Atherosclerosis Co-Depression From the Microbiota-Gut-Brain Axis
por: Hu, Ke, et al.
Publicado: (2022) -
The role of the gut microbiome and its metabolites in cerebrovascular diseases
por: Xu, Hongyu, et al.
Publicado: (2023) -
Gut microbiome interacts with pregnancy hormone metabolites in gestational diabetes mellitus
por: Lyu, Xuejing, et al.
Publicado: (2023) -
Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality
por: Xia, Yi, et al.
Publicado: (2022)